CONTEXT: Serious noninfectious complications are far more likely to occur than viral disease transmission from blood component transfusion. OBJECTIVE: To compile a comprehensive list of the noninfectious risks of transfusion, examples of published risk estimates, and summaries of recent information regarding cause, prevention, or management of noninfectious transfusion risks. DATA SOURCES: Information was obtained from peer-reviewed English-language medical journal publications since 1990. CONCLUSIONS: Early complications, although potentially more serious, usually occur less frequently (<1 in 1000 transfusions) than late complications, which often affect more than 1% of recipients. Areas of active investigation and discussion include acute hemolytic reactions, transfusion-related acute lung injury, red cell alloimmunization, platelet transfusion refractoriness, and transfusion immunosuppression. Continued effort toward research and education to promote recognition and prevention of noninfectious complications associated with blood components is warranted.
CONTEXT: Serious noninfectious complications are far more likely to occur than viral disease transmission from blood component transfusion. OBJECTIVE: To compile a comprehensive list of the noninfectious risks of transfusion, examples of published risk estimates, and summaries of recent information regarding cause, prevention, or management of noninfectious transfusion risks. DATA SOURCES: Information was obtained from peer-reviewed English-language medical journal publications since 1990. CONCLUSIONS: Early complications, although potentially more serious, usually occur less frequently (<1 in 1000 transfusions) than late complications, which often affect more than 1% of recipients. Areas of active investigation and discussion include acute hemolytic reactions, transfusion-related acute lung injury, red cell alloimmunization, platelet transfusion refractoriness, and transfusion immunosuppression. Continued effort toward research and education to promote recognition and prevention of noninfectious complications associated with blood components is warranted.
Authors: Emmanuel Fadeyi; Sharon Adams; Brett Peterson; Julia Hackett; Phyllis Byrne; Harvey G Klein; Francesco M Marincola; Susan F Leitman; David F Stroncek Journal: Transfusion Date: 2008-04-15 Impact factor: 3.157
Authors: Cornelius L Varnado; Todd L Mollan; Ivan Birukou; Bryan J Z Smith; Douglas P Henderson; John S Olson Journal: Antioxid Redox Signal Date: 2012-11-16 Impact factor: 8.401
Authors: Hong Man Yoon; Young-Woo Kim; Byung Ho Nam; Daniel Reim; Bang Wool Eom; Ji Yeon Park; Keun Won Ryu Journal: World J Gastroenterol Date: 2014-02-21 Impact factor: 5.742